The Main Bottleneck for Non-Metastatic Pancreatic Adenocarcinoma in Past Decades: A Population-Based Analysis

BACKGROUND: Despite recent advancements in surgical techniques, chemotherapy, and radiotherapy, the 5-year survival rate of patients with pancreatic ductal adenocarcinoma (PDAC) remains an unsatisfactory ~8%. MATERIAL/METHODS: Data were extracted to identify patients with non-metastatic pancreatic a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Med Sci Monit
Autors principals: Li, Yuqiang, Liu, Wenxue, Zhao, Lilan, Xu, Yang, Yan, Tingyu, Yang, Qionghui, Pei, Qian, Güngör, Cenap
Format: Artigo
Idioma:Inglês
Publicat: International Scientific Literature, Inc. 2020
Matèries:
Database Analysis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7212811/
https://ncbi.nlm.nih.gov/pubmed/32358953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.921515
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars